HIV-associated brain pathology in the United Kingdom: an epidemiological study.
OBJECTIVE
To examine the epidemiology of HIV-associated neuropathology in the United Kingdom and to investigate whether the prevalence of different forms of HIV-associated brain pathology varies with exposure category.


METHODS
The study was a cross-sectional survey; data was analysed from the Medical Research Council National AIDS Neuropathology database.


METHODS
Information was gathered from throughout England, Scotland and Wales.


METHODS
Individuals who died from AIDS in the United Kingdom and had a postmortem examination. The database comprised 7% of all AIDS deaths in the United Kingdom between 1982 and 1993.


RESULTS
Neuropathological diagnoses based on internationally accepted neuropathological terminology of AIDS-related brain lesions.


RESULTS
HIV encephalitis was the most prevalent pathological diagnosis, occurring in 25.3% [95% confidence interval (CI), 21.0-29.6] of the study sample. Statistically significant independent associations for the occurrence of HIV encephalitis were found for injecting drug use (odds ratio, 6.86; 95% CI, 2.91-16.17), and age less than 30 years at death (odds ratio, 3.58; 95% CI, 1.99-6.44). Vascular lesions were significantly higher among blood product recipients, 95% of whom were haemophiliacs.


CONCLUSIONS
This was the first epidemiological investigation of HIV-associated brain pathology in the United Kingdom. HIV encephalitis appeared to occur more frequently in injecting drug users and those who died younger. Whereas the findings must be interpreted cautiously, one hypothesis was that differences in the route of transmission may have affected the manifestation of HIV-associated brain damage.
Davies
J
J
Department of Mental Health, Post Graduate Medical School, University of Exeter, UK.
Everall
I P
IP
Weich
S
S
McLaughlin
J
J
Scaravilli
F
F
Lantos
P L
PL
D015526:AIDS Dementia Complex / Q000150:complications / Q000453:epidemiology* / Q000473:pathology*; D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000453:epidemiology; D000328:Adult; D001921:Brain / Q000473:pathology*; D003430:Cross-Sectional Studies; D003586:Cytomegalovirus Infections / Q000150:complications / Q000453:epidemiology; D004660:Encephalitis / Q000150:complications / Q000453:epidemiology; D018792:Encephalitis, Viral / Q000150:complications / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000473:pathology*; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications / Q000453:epidemiology; D016483:Lymphoma, AIDS-Related / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000150:complications; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000453:epidemiology; D006113:United Kingdom / Q000453:epidemiology